Detection of a novel mutation in the ryanodine receptor gene in an Irish malignant hyperthermia pedigree: correlation of the IVCT response with the affected and unaffected haplotypes.

No abstract is available for this paper.

• Publication year

  1997

• Venue

  Journal of Medical Genetics

• Publication date

  1997-04-01

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1136/jmg.34.4.291PMID 9138151PMCID PMC1050914
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Malignant Hyperthermia

  2005cited by this paper
• Mapping of a further malignant hyperthermia susceptibility locus to chromosome 3q13.1.

  1995cited by this paper
• Stabilization of calcium release channel (ryanodine receptor) function by FK506-binding protein.

  1994cited by this paper
• A Clinical Grading Scale to Predict Malignant Hyperthermia Susceptibility

  1994cited by this paper
• The substitution of Arg for Gly2433 in the human skeletal muscle ryanodine receptor is associated with malignant hyperthermia.

  1994cited by this paper
• The point mutation Arg615-->Cys in the Ca2+ release channel of skeletal sarcoplasmic reticulum is responsible for hypersensitivity to caffeine and halothane in malignant hyperthermia.

  1994cited by this paper
• Detection of a novel RYR1 mutation in four malignant hyperthermia pedigrees.

  1994cited by this paper
• Localization of the gene encoding the alpha 2/delta-subunits of the L-type voltage-dependent calcium channel to chromosome 7q and analysis of the segregation of flanking markers in malignant hyperthermia susceptible families.

  1994cited by this paper
• Detection of a novel common mutation in the ryanodine receptor gene in malignant hyperthermia: implications for diagnosis and heterogeneity studies.

  1994cited by this paper
• Structure and function of ryanodine receptors.

  1994cited by this paper
• Biochemical evidence for a complex involving dihydropyridine receptor and ryanodine receptor in triad junctions of skeletal muscle.

  1994cited by this paper
• Mutation screening of the RYR1 gene in malignant hyperthermia: detection of a novel Tyr to Ser mutation in a pedigree with associated central cores.

  1994cited by this paper
• Mutations in the ryanodine receptor gene in central core disease and malignant hyperthermia

  1993cited by this paper
• A mutation in the human ryanodine receptor gene associated with central core disease

  1993cited by this paper
• Dinucleotide repeat polymorphism at the D19S191 locus.

  1992cited by this paper
• Polymorphisms and deduced amino acid substitutions in the coding sequence of the ryanodine receptor (RYR1) gene in individuals with malignant hyperthermia.

  1992cited by this paper
• Malignant hyperthermia.

  1992cited by this paper
• Evidence for genetic heterogeneity of malignant hyperthermia susceptibility.

  1992cited by this paper
• Evidence for the localization of a malignant hyperthermia susceptibility locus (MHS2) to human chromosome 17q.

  1992cited by this paper
• FK506 binding protein associated with the calcium release channel (ryanodine receptor).

  1992cited by this paper
• Trinucleotide repeat polymorphism at the D19S190 locus.

  1992cited by this paper
• Cosegregation of porcine malignant hyperthermia and a probable causal mutation in the skeletal muscle ryanodine receptor gene in backcross families.

  1991cited by this paper
• Identification of a mutation in porcine ryanodine receptor associated with malignant hyperthermia.

  1991cited by this paper
• A substitution of cysteine for arginine 614 in the ryanodine receptor is potentially causative of human malignant hyperthermia.

  1991cited by this paper
• Dinucleotide repeat polymorphism at the RYR1 locus (19q13.1).

  1991cited by this paper
• Molecular cloning of cDNA encoding human and rabbit forms of the Ca2+ release channel (ryanodine receptor) of skeletal muscle sarcoplasmic reticulum.

  1990cited by this paper
• The human ryanodine receptor gene: its mapping to 19q13.1, placement in a chromosome 19 linkage group, and exclusion as the gene causing myotonic dystrophy.

  1990cited by this paper
• Prediction of malignant hyperthermia susceptibility: statistical evaluation of clinical signs.

  1990cited by this paper
• Abnormal sarcoplasmic reticulum ryanodine receptor in malignant hyperthermia.

  1988cited by this paper
• Dantrolene—An Update

  1987cited by this paper
• Inheritance of Malignant Hyperthermia—A Review of Published Data

  1987cited by this paper
• The European MH Group: Protocol for in Vitro Diagnosis of Susceptibility to MH and Preliminary Results

  1987cited by this paper
• Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction.

  1987cited by this paper
• Intracellular ionized calcium concentration in muscles from humans with malignant hyperthermia

  1985cited by this paper
• Abnormality in calcium release from skeletal sarcoplasmic reticulum of pigs susceptible to malignant hyperthermia.

  1983cited by this paper

• Clinical Pharmacogenetics Implementation Consortium (CPIC) Guideline for the Use of Potent Volatile Anesthetic Agents and Succinylcholine in the Context of RYR1 or CACNA1S Genotypes

  2019cites this paper
• Next-generation Sequencing of RYR1 and CACNA1S in Malignant Hyperthermia and Exertional Heat Illness

  2015cites this paper
• Utility of next generation sequencing in genetic diagnosis of early onset neuromuscular disorders

  2015cites this paper
• Correction

  2015cites this paper
• Guanosine diphosphate-mannose:GlcNAc2-PP-dolichol mannosyltransferase deficiency (congenital disorders of glycosylation type Ik): five new patients and seven novel mutations

  2010cites this paper
• Review in Muscle Nerve Genetics and pathogenesis of malignant hyperthermia

  2009cites this paper
• Disease-causing mutations of calcium channels

  2008cites this paper
• Diseases associated with altered ryanodine receptor activity.

  2007cites this paper
• Denaturing High Performance Liquid Chromatography Screening of Ryanodine Receptor Type 1 Gene in Patients with Malignant Hyperthermia in Taiwan and Identification of a Novel Mutation (Y522C)

  2005cites this paper
• Ryanodine receptor 1 mutations, dysregulation of calcium homeostasis and neuromuscular disorders.

  2005cites this paper
• Correlations between genotype and pharmacological, histological, functional, and clinical phenotypes in malignant hyperthermia susceptibility

  2005cites this paper
• Minicore myopathy with ophthalmoplegia caused by mutations in the ryanodine receptor type 1 gene

  2005cites this paper
• Ryanodine receptors.

  2005cites this paper
• Recent advances in the diagnosis of malignant hyperthermia susceptibility: How confident can we be of genetic testing?

  2003cites this paper
• Screening for mutations in the RYR1 gene in families with malignant hyperthermia

  2003cites this paper
• 1.5 Kongenitale und Mitochondriale Myopathien

  2002cites this paper
• Regulation of calcium release by interdomain interaction within ryanodine receptors.

  2002cites this paper
• RYR1 mutations causing central core disease are associated with more severe malignant hyperthermia in vitro contracture test phenotypes

  2002cites this paper
• Current concepts in malignant hyperthermia.

  2002cites this paper
• Spectroscopic monitoring of local conformational changes during the intramolecular domain-domain interaction of the ryanodine receptor.

  2002cites this paper
• Genotype‐phenotype comparison of the Swiss malignant hyperthermia population

  2001cites this paper
• Malignant hyperthermia.

  2001cites this paper
• Identification and functional characterization of a novel ryanodine receptor mutation causing malignant hyperthermia in North American and South American families

  2001cites this paper
• Guidelines for molecular genetic detection of susceptibility to malignant hyperthermia.

  2001cites this paper
• A novel ryanodine receptor mutation and genotype-phenotype correlation in a large malignant hyperthermia New Zealand Maori pedigree.

  2000cites this paper
• Genetics and pathogenesis of malignant hyperthermia

  2000cites this paper
• Ryanodine receptor mutations in malignant hyperthermia and central core disease

  2000cites this paper
• Malignant hyperthermia: advances in clinical management and diagnosis.

  2000cites this paper
• [Malignant hyperthermia].

  2000cites this paper
• Molecular aspects of malignant hyperthermia and central core disease

  2000cites this paper
• Kongenitale und Mitochondriale Myopathien

  2000cites this paper
• Mutation screening of the RYR1 gene and identification of two novel mutations in Italian malignant hyperthermia families

  1999cites this paper
• Measurement of Resting Cytosolic Ca2+ Concentrations and Ca2+ Store Size in HEK-293 Cells Transfected with Malignant Hyperthermia or Central Core Disease Mutant Ca2+ Release Channels*

  1999cites this paper
• Screening of the ryanodine receptor gene in 105 malignant hyperthermia families: novel mutations and concordance with the in vitro contracture test.

  1999cites this paper
• PATHOGENESIS OF MALIGNANT HYPERTHERMIA

  1999cites this paper
• Voltage-gated ion channels and hereditary disease.

  1999cites this paper
• Genetic analysis with calcium-induced calcium release test in Japanese malignant hyperthermia susceptible (MHS) families.

  1999cites this paper
• Malignant hyperthermia: advances in diagnostics and management.

  1999cites this paper
• Malignant hyperthermia and central core disease: disorders of Ca2+ release channels.

  1998cites this paper
• Ryanodine receptors and their role in genetic diseases (review).

  1998cites this paper
• Intracellular calcium homeostasis in human primary muscle cells from malignant hyperthermia-susceptible and normal individuals. Effect Of overexpression of recombinant wild-type and Arg163Cys mutated ryanodine receptors.

  1998cites this paper
• Malignant hyperthermia and central core disease: disorders of Ca2+ release channels.

  1998cites this paper
• Identification of novel mutations in the ryanodine-receptor gene (RYR1) in malignant hyperthermia: genotype-phenotype correlation.

  1998influential citation
• Caffeine and Halothane Sensitivity of Intracellular Ca2+ Release Is Altered by 15 Calcium Release Channel (Ryanodine Receptor) Mutations Associated with Malignant Hyperthermia and/or Central Core Disease*

  1997cites this paper
• Detection of a novel mutation at amino acid position 614 in the ryanodine receptor in malignant hyperthermia.

  1997cites this paper